Zimmer Biomet Holdings Gross Margin 2010-2025 | ZBH
Current and historical gross margin for Zimmer Biomet Holdings (ZBH) over the last 10 years. The current gross profit margin for Zimmer Biomet Holdings as of March 31, 2025 is %.
| Zimmer Biomet Holdings Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2025-03-31 | $7.70B | $5.47B | 71.06% |
| 2024-12-31 | $7.68B | $5.49B | 71.48% |
| 2024-09-30 | $7.60B | $5.45B | 71.78% |
| 2024-06-30 | $7.53B | $5.40B | 71.77% |
| 2024-03-31 | $7.45B | $5.36B | 71.88% |
| 2023-12-31 | $7.40B | $5.31B | 71.81% |
| 2023-09-30 | $7.28B | $5.21B | 71.62% |
| 2023-06-30 | $7.20B | $5.16B | 71.72% |
| 2023-03-31 | $7.11B | $5.09B | 71.58% |
| 2022-12-31 | $6.94B | $4.92B | 70.91% |
| 2022-09-30 | $6.89B | $4.86B | 70.47% |
| 2022-06-30 | $6.91B | $4.87B | 70.49% |
| 2022-03-31 | $6.89B | $4.87B | 70.63% |
| 2021-12-31 | $6.83B | $4.87B | 71.30% |
| 2021-09-30 | $6.24B | $4.47B | 71.69% |
| 2021-06-30 | $6.48B | $4.64B | 71.55% |
| 2021-03-31 | $5.94B | $4.17B | 70.19% |
| 2020-12-31 | $6.13B | $4.30B | 70.25% |
| 2020-09-30 | $7.07B | $5.00B | 70.81% |
| 2020-06-30 | $7.03B | $5.00B | 71.14% |
| 2020-03-31 | $7.79B | $5.61B | 71.94% |
| 2019-12-31 | $7.98B | $5.73B | 71.78% |
| 2019-09-30 | $7.93B | $5.67B | 71.57% |
| 2019-06-30 | $7.87B | $5.63B | 71.45% |
| 2019-03-31 | $7.89B | $5.64B | 71.49% |
| 2018-12-31 | $7.93B | $5.66B | 71.36% |
| 2018-09-30 | $7.93B | $5.65B | 71.25% |
| 2018-06-30 | $7.91B | $5.66B | 71.52% |
| 2018-03-31 | $7.85B | $5.65B | 72.02% |
| 2017-12-31 | $7.80B | $5.67B | 72.68% |
| 2017-09-30 | $7.73B | $5.57B | 72.03% |
| 2017-06-30 | $7.75B | $5.61B | 72.38% |
| 2017-03-31 | $7.74B | $5.48B | 70.88% |
| 2016-12-31 | $7.67B | $5.29B | 68.94% |
| 2016-09-30 | $7.61B | $5.18B | 68.05% |
| 2016-06-30 | $7.53B | $5.03B | 66.78% |
| 2016-03-31 | $6.77B | $4.61B | 68.11% |
| 2015-12-31 | $6.00B | $4.20B | 69.97% |
| 2015-09-30 | $5.29B | $3.84B | 72.71% |
| 2015-06-30 | $4.63B | $3.44B | 74.37% |
| 2015-03-31 | $4.65B | $3.42B | 73.65% |
| 2014-12-31 | $4.67B | $3.43B | 73.38% |
| 2014-09-30 | $4.69B | $3.44B | 73.27% |
| 2014-06-30 | $4.66B | $3.37B | 72.40% |
| 2014-03-31 | $4.65B | $3.37B | 72.50% |
| 2013-12-31 | $4.62B | $3.36B | 72.60% |
| 2013-09-30 | $4.56B | $3.32B | 72.74% |
| 2013-06-30 | $4.52B | $3.34B | 74.05% |
| 2013-03-31 | $4.47B | $3.34B | 74.73% |
| 2012-12-31 | $4.47B | $3.35B | 74.83% |
| 2012-09-30 | $4.46B | $3.33B | 74.66% |
| 2012-06-30 | $4.47B | $3.34B | 74.78% |
| 2012-03-31 | $4.48B | $3.35B | 74.74% |
| 2011-12-31 | $4.45B | $3.33B | 74.82% |
| 2011-09-30 | $4.42B | $3.33B | 75.29% |
| 2011-06-30 | $4.35B | $3.29B | 75.67% |
| 2011-03-31 | $4.27B | $3.25B | 76.06% |
| 2010-12-31 | $4.22B | $3.21B | 76.00% |
| 2010-09-30 | $4.19B | $3.18B | 75.84% |
| 2010-06-30 | $4.20B | $3.16B | 75.17% |
| 2010-03-31 | $4.17B | $3.14B | 75.28% |
| 2009-12-31 | $4.10B | $3.10B | 75.78% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $18.463B | $7.679B |
| Zimmer Biomet is a leading musculoskeletal healthcare company that designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $223.656B | 26.24 |
| Boston Scientific (BSX) | United States | $157.946B | 37.72 |
| Stryker (SYK) | United States | $152.832B | 31.96 |
| EssilorLuxottica (ESLOY) | France | $137.378B | 0.00 |
| Medtronic (MDT) | Ireland | $117.532B | 16.66 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.462B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.306B | 24.72 |
| ResMed (RMD) | United States | $40.680B | 30.56 |
| Agilent Technologies (A) | United States | $33.534B | 21.86 |
| GE HealthCare Technologies (GEHC) | United States | $32.803B | 15.37 |
| Koninklijke Philips (PHG) | Netherlands | $25.816B | 17.08 |
| Terumo (TRUMY) | Japan | $25.125B | 32.63 |
| Insulet (PODD) | United States | $20.991B | 82.39 |
| Baxter (BAX) | United States | $14.395B | 10.75 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.547B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.805B | 23.68 |
| Lantheus Holdings (LNTH) | United States | $4.970B | 12.54 |
| Perrigo (PRGO) | Ireland | $3.781B | 9.58 |
| Prestige Consumer Healthcare (PBH) | United States | $3.713B | 16.58 |
| Haemonetics (HAE) | United States | $3.644B | 16.60 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.383B | 28.11 |
| ICU Medical (ICUI) | United States | $3.088B | 22.77 |
| LeMaitre Vascular (LMAT) | United States | $1.852B | 41.40 |
| AtriCure (ATRC) | United States | $1.739B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.643B | 11.30 |
| Acuren (TIC) | United States | $1.391B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.271B | 28.60 |
| AdaptHealth (AHCO) | United States | $1.232B | 12.51 |
| Phibro Animal Health (PAHC) | United States | $1.132B | 14.47 |
| BioLife Solutions (BLFS) | United States | $1.044B | 0.00 |
| Neogen (NEOG) | United States | $1.019B | 16.19 |
| Curaleaf Holdings (CURLF) | Canada | $0.939B | 0.00 |
| InMode (INMD) | Israel | $0.879B | 8.13 |
| Kestra Medical Technologies (KMTS) | United States | $0.856B | 0.00 |
| Valneva SE (VALN) | France | $0.651B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.616B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.614B | 0.00 |
| Evolus (EOLS) | United States | $0.578B | 0.00 |
| Owens & Minor (OMI) | United States | $0.549B | 4.56 |
| CeriBell (CBLL) | United States | $0.539B | 0.00 |
| Surmodics (SRDX) | United States | $0.535B | 0.00 |
| ZimVie (ZIMV) | United States | $0.526B | 20.52 |
| SNDL (SNDL) | Canada | $0.378B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.374B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.342B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.315B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.308B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.307B | 11.29 |
| Quanterix (QTRX) | United States | $0.304B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.254B | 75.33 |
| Cerus (CERS) | United States | $0.250B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.244B | 20.60 |
| OraSure Technologies (OSUR) | United States | $0.239B | 0.00 |
| Omeros (OMER) | United States | $0.238B | 0.00 |
| Biote (BTMD) | United States | $0.237B | 6.68 |
| Sanara MedTech (SMTI) | United States | $0.223B | 0.00 |
| Brainsway (BWAY) | Israel | $0.222B | 58.75 |
| Canopy Growth (CGC) | Canada | $0.215B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.215B | 0.00 |
| Exagen (XGN) | United States | $0.190B | 0.00 |
| Organigram Global (OGI) | Canada | $0.184B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.183B | 15.07 |
| Vireo Growth (VREOF) | United States | $0.177B | 0.00 |
| High Tide (HITI) | Canada | $0.172B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.168B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.131B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.117B | 14.37 |
| Jushi Holdings (JUSHF) | United States | $0.112B | 0.00 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.098B | 12.62 |
| MacroGenics (MGNX) | United States | $0.097B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.096B | 0.00 |
| Safety Shot (SHOT) | United States | $0.088B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Zynex (ZYXI) | United States | $0.075B | 0.00 |
| Veru (VERU) | United States | $0.072B | 0.00 |
| Apyx Medical (APYX) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.067B | 0.00 |
| Agape ATP (ATPC) | $0.064B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.058B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.058B | 0.00 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| Nephros (NEPH) | United States | $0.037B | 50.43 |
| United-Guardian (UG) | United States | $0.036B | 12.51 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |